Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MOGAMULIZUMAB vs MOMETASONE FUROATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MOGAMULIZUMAB vs MOMETASONE FUROATE: Safety Overview

Metric MOGAMULIZUMAB MOMETASONE FUROATE
Total FAERS Reports 441 11,619
Deaths Reported 128 138
Death Rate 29.0% 1.2%
Hospitalizations 181 1,865
Average Patient Age 64.5 yrs 56.1 yrs
% Female Patients 38.1% 65.1%
FDA Approval Date N/A Apr 18, 2007
Manufacturer Kyowa Kirin, Inc. Bryant Ranch Prepack
Route INTRAVENOUS TOPICAL
Marketing Status N/A Discontinued